Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuronox vs Botox in Glabellar Lines
NCT03216408Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Mar 2016
- Primary completion
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of botulinum toxin type A in glabellar lines, sponsored by Medytox Inc.. Started Mar 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT03216408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03216408.